The accessibility of oral drugs plays an important role in the oral drug delivery market, with oral medications being widely available in pharmacies, patients can easily access and obtain their prescribed medications without needing specialized medical facilities or professionals. This accessibility factor contributes to the overall growth and adoption of oral drug delivery methods, as patients can conveniently and independently manage their medication regimens. The widespread availability of oral drugs in pharmacies ensures patients have timely access to their medications, promoting medication adherence and supporting the demand for oral drug delivery solutions in the market.
According to Data Bridge Market Research the Oral Drug Delivery Market growth at a rate of 7.60% in the forecast period of 2022 to 2029.
“Rapid Increase in the geriatric population upsurge the market growth”
The global rise in the geriatric population is a key driver for the growth of the oral drug delivery market. With aging, individuals often experience difficulties in swallowing or have reduced dexterity, making traditional drug delivery methods challenging. Oral drug delivery offers a convenient and non-invasive approach, allowing easy ingestion of medications. As the geriatric population continues to increase, the demand for effective and patient-friendly drug delivery systems rises, promoting the adoption of oral drug delivery technologies. This trend is driving the growth of the oral drug delivery market, catering to the specific needs of the elderly population and enhancing medication adherence.
What restraints the growth of oral drug delivery market?
“Risk of needle stick injuries”
The risk of needle stick injuries postures a significant restraint to the growth of the oral drug delivery market. Needle stick injuries can occur during the administration of injectable medications, increasing the risk of infection and transmission of blood borne diseases. As the oral drug delivery market offers a needle-free alternative for drug administration, the prevalence of needle stick injuries is a barrier to adopting oral drug delivery methods. Addressing safety concerns and promoting awareness about the benefits of oral drug delivery in terms of patient comfort and reduced risk of needle stick injuries is crucial for overcoming this restraint and promoting market growth.
Segmentation: Oral Drug Delivery Market
The oral drug delivery market is segmented on the basis of type, application and end user.
- On the basis of type, the oral drug delivery market is segmented into controlled release, orodispersible tablets and taste making.
- On the basis of application, the oral drug delivery market is segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications.
- On the basis of end user, the oral drug delivery market is segmented into hospitals, ambulatory surgical centers, home care settings, diagnostic centers, and others.
Regional Insights: North America is expected to dominate the oral drug delivery market
North America holds a dominant position in the oral drug delivery market due to the rising prevalence of chronic diseases like cancer, respiratory allergies, and diabetes. The region experiences a higher demand for effective drug delivery methods to address these conditions. This trend has propelled North America to be a frontrunner in the market, as pharmaceutical companies and researchers focus on developing innovative oral drug delivery technologies to cater to the needs of patients within the region.
The Asia-Pacific (APAC) region is projected to experience substantial growth in the forecast period of 2022 to 2029, primarily driven by the surge in research and development activities within the region. With a focus on advancing healthcare and pharmaceutical innovations, APAC has witnessed increased investments in R&D. This has positioned the region as a promising market for developing and adopting new drug delivery technologies, making it a key player in the global oral drug delivery market.
To know more about the study visit, https://www.databridgemarketresearch.com/zh/reports/global-oral-drug-delivery-market
The Prominent Key Players Operating in the Oral Drug Delivery Market Include:
- AbbVie Inc. (U.S.)
- EnteraBio Ltd. (Israel)
- Catalent, Inc. (U.S.)
- Novartis AG (Switzerland)
- Biocon (India)
- Novo Nordisk A/S (Denmark)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Bayer AG (Germany)
- 3M (U.S.)
- Evonik Industries (Germany)
- Skyepharma Production SAS (France)
- Chimerix (U.S.)
- SAMYANG BIOPHARMACEUTICAL CORPORATION (South Korea)
- Oramed (Israel)
- Emisphere Technologies (U.S.)
- Enteris BioPharma (U.S.)
- AdhexPharma (France)
- ARx, LLC (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of oral drug delivery market companies contact, https://www.databridgemarketresearch.com/zh/contact
Research Methodology: Global Oral Drug Delivery Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
